MoCRA Status Report: An In-Depth Look at the Industry’s Response to the Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
John Bailey Jr., Ph. D.
Independent Advisor
EAS Consulting Group
Former Director of FDA’s Office of Cosmetics and Colors
Angela Diesch
Partner & Cosmetics Industry Practice Lead
Amin Talati Wasserman
Dan Kolhoff
Director of Regulatory & Legal Affairs
John Paul Mitchell
MoCRA has been a game changer for the cosmetics industry. This panel will examine the status of the law and FDA guidance as well as where companies are and how they are adapting.
- Examining MoCRA and related FDA guidance issued thus far
- Analyzing how MoCRA has affected the beauty industry and what companies are doing to adapt
- Assessing where large, small, and independent manufacturers are with devising plans for product registration, listing, and good manufacturing practices (cGMPS)
- Examining the new FDA cosmetics registration program